Endometrial cancer drug cuts progression or death risk 41%

• by Mouj Hijazi

• October 27, 2026

How much of a cancer drug is too much? Patients, researchers challenge FDA-approved dosages

“There is incredible uncertainty in drug dosing.”

• by Arthur Allen

• August 20, 2026

• 15 min

Cancer Treatment During Pregnancy and Maternal and Infant Outcomes: A Descriptive Cohort Study Using a Japanese Claims Database

• by Masami Tsuchiya, Tomofumi Ishikawa, Takamasa Sakai, Satoko Hori, Taku Obara

• October 16, 2026

Dana-Farber Research News 06.15.2026

This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from May 16 - 31.

• by

• June 15, 2026

• 27 min